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We read with interest the recent article by Mestres et al.1
and would like to congratulate our colleagues on such a
high number of cases. In our recent review we found only
23 cases reported between 1951 to 2014.2 The authors
conclude that bypass remains a safe and effective option.1
Given the fact that donor artery aneurysm formation is
the result of long-term (10e15 years from the time of
construction) pathophysiological processes, bypass might
be a safe but not necessarily the best long-term solution.1e3
Firstly, recognition of a “non-affected arterial section” by
chronic aneurysmal degeneration for the proximal and
distal landing zone of the bypass remains difﬁcult. Secondly,
the majority of these patients present with pain as a
consequence of compression of nerves, veins, and/or local
tissue, thus a complete resection and end to end grafting
might be more effective in alleviating symptoms and
restoring ﬂow.2 Thirdly, aneurysmectomy followed by
interposition grafting (vein, PTFE, and composite) tends to
maintain more of the natural anatomy thus reducing the
susceptibility of the new bypass to trauma, kinking and/or
compression.2 Finally, only one case (n ¼ 1) in the series
(n ¼ 12) was treated by aneurysmectomy and therefore the
authors have not provided adequate numbers for compar-
ison of long-term outcomes among the two surgical mo-
dalities of exclusion and bypass versus aneurysm resection
and interposition grafting.1
Overall, we acknowledge that such cases pose a signiﬁ-
cant challenge both in detection and surgical correction.
With the longer duration of AVF in combination withprolonged life, it is perhaps no surprise that we are wit-
nessing more of these “inﬂow aneurysmal degenerations”
that were once rare in clinical practice.
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Thank you for your comments. As you suggest, aneurysmal
degeneration of the inﬂow artery is not a common
complication after AVF, but its frequency will probably rise
as the life expectancy of patients improves.
Responding to your comments, ﬁrstly, we agree that it
is hard to ﬁnd a safe proximal and distal “non-affected”
artery, so there is a risk of proximal or distal aneurysmal
degeneration (as described in our series), but this is not
common. Thus, autogenous bypass remains safe, and is
the most effective treatment option, even if complications
